New cancer drug trial seeks to target tumors with precision
NCT ID NCT06803680
Summary
This is an early-stage study to test a new drug called BGB-B455 in people with advanced solid tumors that have a specific protein called CLDN6. The main goals are to find a safe and effective dose and to understand what side effects participants experience. The drug is designed to help the body's immune system attack cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Adventhealth
RECRUITINGCelebration, Florida, 34747-4606, United States
-
Avera Cancer Institute
RECRUITINGSioux Falls, South Dakota, 57105-2108, United States
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
-
Blacktown Cancer and Haematology Centre
RECRUITINGBlacktown, New South Wales, NSW 2148, Australia
-
Fred Hutchinson Cancer Research Center
RECRUITINGSeattle, Washington, 98109-4433, United States
-
Fudan University Shanghai Cancer Centerpudong
RECRUITINGShanghai, Shanghai Municipality, 201321, China
-
Liverpool Hospital
RECRUITINGLiverpool, New South Wales, NSW 2170, Australia
-
Mater Cancer Care Centre
RECRUITINGSouth Brisbane, Queensland, QLD 4101, Australia
-
Next Oncology
RECRUITINGSan Antonio, Texas, 78229-6028, United States
-
Shanxi Provincial Cancer Hospital
RECRUITINGTaiyuan, Shanxi, 030013, China
-
Sidney Kimmel Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19107-4307, United States
-
Sun Yat Sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital of Nanchang University Branch Donghu
RECRUITINGNanchang, Jiangxi, 330006, China
Conditions
Explore the condition pages connected to this study.